THE DIFFICULTIES IN MAKING A DIAGNOSIS OF CJD

Similar documents
DIAGNOSIS & TREATMENT OF HUMAN PRION DISEASES

Creutzfeldt-Jakob Disease

Genetic CJD INFORMATION SHEET 2 JANUARY Introduction to genetic CJD. Inheriting a risk of CJD

The Blackouts Checklist i

Creutzfelt-Jakob Disease (CJD)

Appendix A: Disease-Specific Chapters

The Fainting Checklist

Appendix B: Provincial Case Definitions for Reportable Diseases

Chronic Wasting Disease (CWD)

Creutfeldt-Jakob draft policy December 2016

LEVEL 3 CERTIFICATE / DIPLOMA 4463U10-1A. MEDICAL SCIENCE UNIT 1: Human Health and Disease

FAMILY EDITION IN THIS ISSUE

PRION SURVEILLANCE IN PRIMARY IMMUNODEFICIENCY PATIENTS:

CREUTZFELDT-JAKOB DISEASE (CJD), CLASSIC

Iatrogenic CJD INFORMATION SHEET 3 JANUARY Our first awareness of prion diseases

PATIENTS WITH MULTIPLE SCLEROSIS

CREUTZFELDT-JAKOB DISEASE (CJD)

Creutzfeldt-Jakob Disease Fact Sheet

Human prion disease in Piemonte and Valle d Aosta, Italy: the experience of the reference center for human prion disease and a case description.

Young Patient Suffers Cardiac Arrest and Brain Damage After Delayed Referral to Specialist

Diagnosing Variant Creutzfeldt-Jakob Disease with the Pulvinar Sign: MR Imaging Findings in 86 Neuropathologically Confirmed Cases

Mandate and New Programs

Grand-round meeting for Dementia - A patient with rapidly progressing dementia. Dr. Ho Ka Shing Tuen Mun Hospital

Creutzfeldt-Jakob disease (CJD)

Early Onset Dementia From the background to the foreground

Prion diseases or transmissible spongiform encephalopathies (TSEs)

Deep brain stimulation for difficultto-treat

Development of an ante-mortem & pre-symptomatic diagnostic test for human prion diseases using RT-QuIC & equic assays

Registry of Creutzfeldt-Jakob disease and related disorders (19 years of activity: )

Working together with individuals, families, and medical professionals to offer support and information on Syncope. Do you suffer from unexplained...

CJD (Creutzfeldt-Jakob disease)

Treating localised prostate cancer using freezing (cryotherapy) needles in a targeted area of the prostate

Know the 10 Signs: Early Detection Matters

CJD DISEASE: Image Source: bestpractice.bmj.com

Patient Questionnaire

BRIEFING PAPER THE USE OF RED FLAGS TO IDENTIFY SERIOUS SPINAL PATHOLOGY THE CHRISTIE, GREATER MANCHESTER & CHESHIRE. Version:

Know the 10 Signs: Early Detection Matters

Know the 10 Signs: Early Detection Matters

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Dr Isobel Salter, Dr Sara Ali, Dr Jasavanth Basavaraju, Dr Hemalata Bentur, Dr Maysara Abdelaziz

2010 National Survey. East Kent Hospitals University NHS Trust

2010 National Survey. The North West London Hospitals NHS Trust

2010 National Survey. Royal National Orthopaedic Hospital NHS Trust

2010 National Survey. The Leeds Teaching Hospitals NHS Trust

The Centers for Disease Control and Prevention Report: Prion Disease Activities at CDC

ABCD of CJD (the big picture of Creutzfeldt-Jakob disease)

OLDER PEOPLE WITH DUAL SENSORY LOSS: MEETING THEIR NEEDS. Nicola Venus-Balgobin

2010 National Survey. University College London Hospitals NHS Foundation Trust

Diagnosis and assessment

Don t lose your life to NPH.

2010 National Survey. Northern Lincolnshire and Goole Hospitals NHS Foundation Trust

Let s look a minute at the evidence supporting current cancer screening recommendations.

Neurology. Access Center 24/7 access for referring physicians (866) 353-KIDS (5437)

Spinal cord compression

Variant Creutzfeldt-Jakob disease

STROKE INTRODUCTION OBJECTIVES. When the student has finished this module, he/she will be able to:

Young onset dementia service Doncaster

(4) Parents: Diagnosing epilepsy

PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE

NB: A confirmed diagnosis of scjd can only made with brain tissue obtained upon autopsy

Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society

Seeking treatment for an eating disorder?

Glossary of relevant medical and scientific terms

KPNC Stroke EXPRESS EXpediting the PRocess of Evaluating & Stopping Stroke

HEALTHCARE PROVIDER EDITION IN THIS ISSUE WINTER 2012 INTRODUCTION

Critical Review Form Diagnostic Test

BRAIN DEATH. Frequently Asked Questions 04for the General Public

National Hospital for Neurology and Neurosurgery

What do you know about your prostate? Information for Black men

Dissociative Experiences Scale-II (DES-II) DIRECTIONS

Epilepsy (and first seizure) on the acute take. Phil Smith Consultant Neurologist University Hospital of Wales, Cardiff

How can clinical psychologists help with chronic pain?

THE ETHICS OF INCIDENTAL FINDINGS: RECOMMENDATIONS FOR IRBS AND RESEARCHERS. Andy Kondrat, MA Bioethicist, Donnelley Ethics Program

Critical Review Form Therapy

Denial and Unawareness in Huntington s Disease

DEVELOPMENTAL BEHAVIOURAL REFERRAL

Mood247.com: Improving Healthcare Information & Integration

An older systematic review looked at the evidence behind the best approach to evaluate acute knee pain in primary care (Ann Int Med.2003;139:575).

Symptom management for adult males and update on adult BMT in UK

GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Shawnia Ryan, MS, LCGC Senior Genetic Counselor University of New Mexico Cancer Center

Lung Cancer: Moving Imaging to the Front of Outpatient Pathways

Dizziness 101 E-Class TAKE HOME POINTS

Use of and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease

Parkinson s Disease Webcast January 31, 2008 Jill Ostrem, M.D. What is Parkinson s Disease?

Recommendations. for Care of Adults with Epilepsy. Seeking the best treatment from the right doctor at the right time!

For a certificate or if you have any questions about the information included in this Journal summary, please contact:

UCLH NHS Foundation Trust. Patient Guide to Gamma Knife Radiosurgery. at The Queen Square Radiosurgery Centre

First seizure. Information for patients

Working Together Locally to Address Multiple Exclusion

Clinical Genetics Welcome to Clinical Genetics

NICE guidelines development Low back pain and sciatica: Management of non-specific low back pain and sciatica

PROCEDURE FOR DEALING WITH MENINGITIS AND MENINGOCOCCAL DISEASE

PRION 2017 Deciphering Neurodegenerative Disorders Edinburgh

An introduction to organ and tissue donation

Introduction to Emergency Medical Care 1

Incisionless surgery to correct protruding ears

Mental Health Strategy. Easy Read

Care and support. for younger women with breast cancer. The breast cancer support charity

Address : S. 27th Street, Suite 201 Franklin, Wisconsin, WebSite :

Your aging brain. Contact your local chapter to learn more. Find a chapter near you at or visit alz.org/findus.

Transcription:

THE DIFFICULTIES IN MAKING A DIAGNOSIS OF CJD Richard Knight National CJD Surveillance Unit University of Edinburgh

TALK GENERAL INTRODUCTION WHAT TIME DOES IT TAKE TO DIAGNOSE SPORADIC CJD? COULD THIS TIME BE SHORTER? TWO ILLUSTRATIVE HISTORIES CONCLUSIONS

GENERAL INTRODUCTION

PRELIMINARY COMMENT 1 PERSPECTIVE

DIFFERENT PERSPECTIVES

DIFFERENT PERSPECTIVES

PRELIMINARY COMMENT 2 SETTING

PRELIMINARY COMMENT 3 DISEASE TYPE

Hans Creutzfeldt Alfons Jakob CJD

DIFFERENT FORMS OF CJD GENETIC CJD IATROGENIC CJD SPORADIC CJD VARIANT CJD

DIFFERENT FORMS: DIFFERING DIAGNOSTIC CONSIDERATIONS GENETIC CJD IATROGENIC CJD SPORADIC CJD VARIANT CJD

DIFFERENT FORMS: DIFFERING DIAGNOSTIC CONSIDERATIONS GENETIC CJD IATROGENIC CJD SPORADIC CJD scjd VARIANT CJD

3 ESSENTIAL PROBLEMS IN DIAGNOSIS RARE DISEASE NO SIMPLE, NON-INVASIVE, CLINICAL TEST DISEASE: UNTREATABLE & FATAL

3 ESSENTIAL PROBLEMS IN DIAGNOSIS RARE DISEASE NO SIMPLE, NON-INVASIVE, CLINICAL TEST DISEASE: UNTREATABLE & FATAL

3 ESSENTIAL PROBLEMS IN DIAGNOSIS RARE DISEASE NO SIMPLE, NON-INVASIVE, CLINICAL TEST DISEASE: UNTREATABLE & FATAL

THE ESSENTIAL PROBLEMS IN DIAGNOSIS RARE DISEASE MOST DOCTORS HAVE LIMITED EXPERTISE THE DIAGNOSIS IS INHERENTLY UNLIKELY

THE ESSENTIAL PROBLEMS IN DIAGNOSIS RARE DISEASE MOST DOCTORS HAVE LIMITED EXPERTISE THE DIAGNOSIS IS INHERENTLY UNLIKELY

THE ESSENTIAL PROBLEMS IN DIAGNOSIS NO SIMPLE, NON-INVASIVE, CLINICAL TEST RELIANCE ON CLINICAL EVOLUTION OVER TIME INVASIVE TESTS CARRY RISKS

THE ESSENTIAL PROBLEMS IN DIAGNOSIS NO SIMPLE, NON-INVASIVE, CLINICAL TEST RELIANCE ON CLINICAL EVOLUTION OVER TIME INVASIVE TESTS CARRY RISKS

THE ESSENTIAL PROBLEMS IN DIAGNOSIS DISEASE: UNTREATABLE & FATAL WANT TO BE CERTAIN OF DIAGNOSIS BEFORE GIVING IT DESIRE TO GIVE PEOPLE TIME NOT USED UP BY TESTS

THE ESSENTIAL PROBLEMS IN DIAGNOSIS DISEASE: UNTREATABLE & FATAL WANT TO BE CERTAIN OF DIAGNOSIS BEFORE GIVING IT DESIRE TO GIVE PEOPLE TIME NOT USED UP BY TESTS

ANOTHER PROBLEM I DON T KNOW WHY IT WASN T DIAGNOSED EARLIER... WHEN I READ ABOUT THE DISEASE, THE SYMPTOMS WERE TYPICAL.

ANOTHER PROBLEM I DON T KNOW WHY IT WASN T DIAGNOSED EARLIER... WHEN I READ ABOUT THE DISEASE, THE SYMPTOMS WERE TYPICAL. BUT THIS IS A RETROSPECTIVE VIEWPOINT

PRESENTING SYMPTOMS MAY SUGGEST SEVERAL CAUSES 1 2 X 3 4 5 6

1 2 X 3 4 5 6

1 2 X 3 4 5 6

1 2 X 3 4 5 6

1 2 X 3 4 5 6 TIME

TIME SYMPTOMS DIAGNOSIS

WHAT TIME DOES IT TAKE? SYMPTOMS DIAGNOSIS of scjd

DELAY COULD THIS TIME BE SHORTER? SYMPTOMS DIAGNOSIS of scjd

WHAT TIME DOES IT TAKE TO DIAGNOSE SPORADIC CJD?

TIME SYMPTOMS UK SPORADIC CJD MEDIAN TIME ONSET-DIAGNOSIS ~3-4 MONTHS DIAGNOSIS

WHY DOES IT TAKE THIS TIME? SYMPTOMS DIAGNOSIS

WHY DOES IT TAKE THIS TIME? SYMPTOMS DIAGNOSIS SOMETHING WRONG

WHY DOES IT TAKE THIS TIME? SYMPTOMS DIAGNOSIS GET MEDICAL ADVICE

WHY DOES IT TAKE THIS TIME? SYMPTOMS DIAGNOSIS OUTCOME OF INITIAL MANAGEMENT

WHY DOES IT TAKE THIS TIME? SYMPTOMS DIAGNOSIS SEE SPECIALIST

WHY DOES IT TAKE THIS TIME? SYMPTOMS DIAGNOSIS RESULTS OF SPECIALIST TESTS

WHY DOES IT TAKE THIS TIME? SYMPTOMS DIAGNOSIS CJD POSSIBLE OR LIKELY

WHY DOES IT TAKE THIS TIME? SYMPTOMS DIAGNOSIS CONSULTATION WITH SURVEILLANCE SYSTEM

WHY DOES IT TAKE THIS TIME? SYMPTOMS DIAGNOSIS FINAL CLINICAL DIAGNOSIS

TIME SYMPTOMS UK SPORADIC CJD MEDIAN TIME ONSET-DIAGNOSIS ~3-4 MONTHS DIAGNOSIS

COULD THIS TIME BE SHORTER?

SYMPTOMS DIAGNOSIS SOMETHING WRONG GET MEDICAL ADVICE SYMPTOMS MAY BE NON-SPECIFIC SYMPTOMS MAY HAVE POSSIBLE EXPLANATION SOME WAITING IS SENSIBLE & REASONABLE TIME VARIES FROM PATIENT TO PATIENT

SYMPTOMS DIAGNOSIS SOMETHING WRONG GET MEDICAL ADVICE SYMPTOMS MAY BE NON-SPECIFIC SYMPTOMS MAY HAVE POSSIBLE EXPLANATION SOME WAITING IS SENSIBLE & REASONABLE TIME VARIES FROM PATIENT TO PATIENT

SYMPTOMS DIAGNOSIS SOMETHING WRONG GET MEDICAL ADVICE SYMPTOMS MAY BE NON-SPECIFIC SYMPTOMS MAY HAVE POSSIBLE EXPLANATION SOME WAITING IS SENSIBLE & REASONABLE TIME VARIES FROM PATIENT TO PATIENT

SYMPTOMS DIAGNOSIS SOMETHING WRONG GET MEDICAL ADVICE SYMPTOMS MAY BE NON-SPECIFIC SYMPTOMS MAY HAVE POSSIBLE EXPLANATION SOME WAITING IS SENSIBLE & REASONABLE TIME VARIES FROM PATIENT TO PATIENT

SYMPTOMS DIAGNOSIS SOMETHING WRONG GET MEDICAL ADVICE MEDIAN TIME: 2 ¼ WEEKS [1 DAY-SEVERAL MONTHS] UK SPORADIC CJD 2006

SYMPTOMS DIAGNOSIS SOMETHING WRONG GET MEDICAL ADVICE SEE SPECIALIST MEDIAN TIME: 6-8 WEEKS [1 DAY-SEVERAL MONTHS] UK SPORADIC CJD 2006

SYMPTOMS DIAGNOSIS SOMETHING WRONG GET MEDICAL ADVICE SEE SPECIALIST CJD POSSIBLE OR LIKELY MEDIAN TIME: 8-12 WEEKS [FEW WEEKS SEVERAL MONTHS] UK SPORADIC CJD 2006

SYMPTOMS DIAGNOSIS SOMETHING WRONG GET MEDICAL ADVICE SEE SPECIALIST CJD POSSIBLE OR LIKELY REFERRAL TO NCJDSU MEDIAN TIME: 12-16 WEEKS [FEW WEEKS SEVERAL MONTHS] UK SPORADIC CJD 2008

TIME SYMPTOMS UK SPORADIC CJD MEDIAN TIME ONSET-DIAGNOSIS ~3-4 MONTHS DIAGNOSIS

THIS TIME TO DIAGNOSIS IS NOT VERY DIFFERENT FROM THAT FOR MANY NEUROLOGICAL DISEASES WHY IS IT A PARTICULAR PROBLEM IN scjd?

THIS TIME TO DIAGNOSIS IS NOT VERY DIFFERENT FROM THAT FOR MANY NEUROLOGICAL DISEASES WHY IS IT A PARTICULAR PROBLEM IN scjd?

scjd IS TYPICALLY VERY RAPIDLY PROGRESSIVE

Percentage of cases DURATION OF ILLNESS IN scjd (n=1084, UK) 100 90 80 70 60 50 40 30 20 10 0 0-4 5- <8 8- <12 12- <18 18-24 >24 Duration of illness in months

Percentage of cases DURATION OF ILLNESS IN scjd (n=1084, UK) 100 90 80 70 60 50 40 30 20 10 0 0-4 5- <8 8- <12 12- <18 18-24 >24 Duration of illness in months

RATE OF PROGRESSION IN scjd RAPID: TYPICAL DIAGNOSTIC PROCESS TAKES TIME INCREASING & SEVERE DISABILITY & NO DIAGNOSIS DIAGNOSIS MAY BE ONLY SHORTLY BEFORE DEATH

SPORADIC CJD in the UK MEDIAN TIME IN MONTHS 2004 2006 2008 ONSET-DEATH 4.5 4.5 4.0 ONSET-DIAGNOSIS 3.95 3.97 3.69

THERE IS NO SIMPLE, NON-INVASIVE, CLINICAL DIAGNOSTIC TEST

THERE IS NO SIMPLE, NON-INVASIVE, CLINICAL DIAGNOSTIC TEST THERE ARE TESTS THAT ARE HELPFUL IN SUPPORTING THE DIAGNOSIS

AIDS TO DIAGNOSIS FOR scjd EEG CSF 14-3-3 PROTEIN TEST BRAIN MRI PASSAGE OF TIME

AIDS TO DIAGNOSIS FOR scjd EEG CSF 14-3-3 PROTEIN TEST BRAIN MRI PASSAGE OF TIME

AIDS TO DIAGNOSIS FOR scjd EEG CSF 14-3-3 PROTEIN TEST BRAIN MRI PASSAGE OF TIME

AIDS TO DIAGNOSIS FOR scjd EEG CSF 14-3-3 PROTEIN TEST BRAIN MRI NONE OF THESE SHOW ABNORMALITIES UNIQUE TO scjd

OTHER DIAGNOSES POSSIBLE SOME OF WHICH ARE POTENTIALLY TREATABLE CERTAIN BLOOD TESTS MRI SCANS SPINAL FLUID EXAMINATIONS ALL TAKE TIME TO DO MAY TAKE TIME FOR RESULTS FATAL & UNTREATABLE ILLNESSES

AIDS TO DIAGNOSIS FOR scjd EEG CSF 14-3-3 PROTEIN TEST BRAIN MRI PASSAGE OF TIME

VITAL FOR DIAGNOSIS OF/EXCLUSION OF OTHER DISEASES EEG CSF 14-3-3 PROTEIN TEST BRAIN MRI PASSAGE OF TIME

Percentage of cases 100 90 80 70 60 50 40 30 20 10 0 DURATION OF ILLNESS IN scjd (n=1084, UK) 0-4 5- <8 8- <12 12- <18 18-24 >24 Duration of illness in months

RATE OF PROGRESSION IN scjd SLOWER: ATYPICAL OFTEN ATYPICAL CLINICAL FEATURES DIAGNOSTIC AIDS (EEG, CSF, MRI) MAY BE LESS HELPFUL RARE FORMS OF ALREADY RARE ILLNESS

SYMPTOMS DIAGNOSIS SOMETHING WRONG GET MEDICAL ADVICE SEE SPECIALIST CJD POSSIBLE OR LIKELY REFERRAL TO NCJDSU DIFFICULT TO SEE HOW COULD (OR SHOULD) TO REDUCE TIME HERE

SYMPTOMS DIAGNOSIS SOMETHING WRONG GET MEDICAL ADVICE SEE SPECIALIST CJD POSSIBLE OR LIKELY REFERRAL TO NCJDSU WHAT ABOUT HERE?

WHY SPECIALIST DIAGNOSIS TAKES TIME NON-SPECIFIC PRESENTATION RARE ILLNESS: INHERENTLY UNLIKEY RARE ILLNESS: UNFAMILIARITY WITH IT FATAL & UNTREATABLE: WANT TO BE CERTAIN NO SIMPLE DIAGNOSTIC TESTS FATAL & UNTREATABLE ILLNESSES

WHY SPECIALIST DIAGNOSIS TAKES TIME NON-SPECIFIC PRESENTATION RARE ILLNESS: INHERENTLY UNLIKEY RARE ILLNESS: UNFAMILIARITY WITH IT FATAL & UNTREATABLE: WANT TO BE CERTAIN NO SIMPLE DIAGNOSTIC TESTS FATAL & UNTREATABLE ILLNESSES

WHY SPECIALIST DIAGNOSIS TAKES TIME NON-SPECIFIC PRESENTATION RARE ILLNESS: INHERENTLY UNLIKEY RARE ILLNESS: UNFAMILIARITY WITH IT FATAL & UNTREATABLE: WANT TO BE CERTAIN NO SIMPLE DIAGNOSTIC TESTS FATAL & UNTREATABLE ILLNESSES

WHY SPECIALIST DIAGNOSIS TAKES TIME NON-SPECIFIC PRESENTATION RARE ILLNESS: INHERENTLY UNLIKEY RARE ILLNESS: UNFAMILIARITY WITH IT FATAL & UNTREATABLE: WANT TO BE CERTAIN NO SIMPLE DIAGNOSTIC TESTS FATAL & UNTREATABLE ILLNESSES

WHY SPECIALIST DIAGNOSIS TAKES TIME NON-SPECIFIC PRESENTATION RARE ILLNESS: INHERENTLY UNLIKEY RARE ILLNESS: UNFAMILIARITY WITH IT FATAL & UNTREATABLE: WANT TO BE CERTAIN NO SIMPLE DIAGNOSTIC TESTS FATAL & UNTREATABLE ILLNESSES

WHY SPECIALIST DIAGNOSIS TAKES TIME NON-SPECIFIC PRESENTATION RARE ILLNESS: INHERENTLY UNLIKEY RARE ILLNESS: UNFAMILIARITY WITH IT FATAL & UNTREATABLE: WANT TO BE CERTAIN NO SIMPLE DIAGNOSTIC TESTS FATAL & UNTREATABLE ILLNESSES

AWARENESS OF DISEASE IN THE UK (& ELSEWHERE) BSE & VARIANT CJD HAVE INCREASED AWARENESS OF CJD IN GENERAL

WHAT DO UK NATIONAL SURVEILLANCE DATA TELL US ABOUT SPECIALIST DIAGNOSIS?

REFERRALS TO NCJDRSU: SUSPECTED CASES [NOT ALL TURN OUT TO HAVE CJD]

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 NUMBER OF REFERRALS TO THE UK NCJDSU 1996-2009 180 160 140 120 100 80 60 40 20 0

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 NUMBER OF REFERRALS TO THE UK NCJDSU 1996-2009 180 160 140 120 100 80 60 40 20 0

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 NUMBER OF REFERRALS TO THE UK NCJDSU 1996-2009 180 160 140 120 100 80 60 40 20 0

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 NUMBER OF REFERRALS TO THE UK NCJDSU 1996-2009 180 160 140 120 100 80 60 40 20 0

SPORADIC CJD CASES ACTUAL CONFIRMED CASES

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 UK NCJDSU: NUMBER OF scjd CASES* 1996-2009 90 80 70 60 50 40 30 20 10 0 *DEFINITE & PROBABLE

REFERRAL (SUSPECT) RATES VARIED & FELL INCREASING NUMBER OF CONFIRMED CASES WHAT DOES THIS TELL US?

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 NUMBER OF REFERRALS TO THE NCJDSU & UK scjd CASES 1996-2009 180 160 140 120 100 80 60 40 20 0 Number of Referrals Number of scjd cases

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 NUMBER OF REFERRALS TO THE NCJDSU & UK scjd CASES 1996-2009 180 160 140 120 100 80 60 40 20 0 Number of Referrals Number of scjd cases

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 NUMBER OF REFERRALS TO THE NCJDSU & UK scjd CASES 1996-2009 180 160 140 120 100 80 60 40 20 0 BETTER RECOGNITION OF CJD CASES BY NEUROLOGISTS REDUCTION IN REFERRAL OF NON-CASES

UK CLINICIANS HAVE IMPROVED IN DIAGNOSIS OF SPORADIC CJD AWARENESS EDUCATION DIAGNOSTIC TESTS* *CSF 14-3-3 and BRAIN MRI

SPORADIC CJD in the UK ONSET-NOTIFICATION 1990 1998 2008 0 0.5 1 1.5 2 2.5 3 3.5 4 MEDIAN TIMES IN MONTHS

SPORADIC CJD in the UK ONSET-NOTIFICATION 1990 1998 2008 0 0.5 1 1.5 2 2.5 3 3.5 4 MEDIAN TIMES IN MONTHS

SPORADIC CJD in the UK ONSET-NOTIFICATION 1990 1998 2008 0 0.5 1 1.5 2 2.5 3 3.5 4 MEDIAN TIMES IN MONTHS

SPORADIC CJD in the UK ONSET-NOTIFICATION 1990 1998 2008 0 0.5 1 1.5 2 2.5 3 3.5 4 MEDIAN TIMES IN MONTHS

UK CLINICIANS HAVE IMPROVED IN DIAGNOSIS OF SPORADIC CJD BUT NOT IMPACTED GREATLY ON TIME TO NOTIFICATION

UK CLINICIANS HAVE IMPROVED IN DIAGNOSIS OF SPORADIC CJD BUT NOT IMPACTED GREATLY ON TIME TO NOTIFICATION AND IN TIME TO DIAGNOSIS

SOME FURTHER INDIRECT EVIDENCE THAT THE DIAGNOSIS OF SPORADIC CJD IS DIFFICULT FATAL & UNTREATABLE ILLNESSES

SUSPECTED scjd REFERRALS SEEN BY NCJDSU in 2008 NUMBER DEFINITE or PROBABLE AT TIME SEEN BY NCDSU STAFF TOTAL: 85 STILL? NOT CJD ~55% scjd

SUSPECTED scjd REFERRALS SEEN BY NCJDSU in 2008 NUMBER DEFINITE or PROBABLE AT TIME SEEN BY NCDSU STAFF TOTAL: 85 STILL? NOT CJD ~55% scjd NCJDSU STAFF VERY EXPERIENCED IN CJD STILL UNCERTAIN IN NEARLY 1/4

SUSPECTED scjd REFERRALS SEEN BY NCJDSU in 2008 NUMBER DEFINITE or PROBABLE AT TIME SEEN BY NCDSU STAFF 68% FINALLY DEFINITE or PROBABLE scjd 13/19 CASES STILL UNCERTAIN AT TIME NCJDSU VISITED WERE IN FACT scjd

SUSPECTED scjd REFERRALS TO NCJDSU in 2008 FINAL OUTCOME TOTAL: 135 * DEF or PROB ~33% ~64%* REFERRED SUSPECTS TO NATIONAL SURVEILLANCE ~1/3 TURN OUT NOT TO BE CJD OF ANY KIND

OTHER DIAGNOSES POSSIBLE (SOME POTENTIALLY TREATABLE) PASSAGE OF TIME AS DIAGNOSTIC TEST ITSELF FATAL & UNTREATABLE ILLNESSES

TWO ILLUSTRATIVE HISTORIES

83 yr old Man (Definite scjd) 1 st seeking advice Referred neurologist Seen by neurologist Admitted to hospital Brain MRI Notified NCJDSU Seen NCJDSU Died 3 weeks 4 weeks 5 weeks 6 weeks 6 ½ weeks 8 weeks 9 weeks 11 weeks

Male 83 (Definite scjd) CJD first suggested 1 st seeking advice Referred neurologist Seen by neurologist Admitted to hospital Brain MRI Notified NCJDSU Seen NCJDSU Died 3 weeks 4 weeks 5 weeks 6 weeks 6 ½ weeks 8 weeks 9 weeks 11 weeks

67 yr old Female (Definite scjd) 1 st saw a doctor Hospital admission Referred neurologist Seen by neurologist Notified to NCJDSU Seen by NCJDSU Died 8 weeks 14 weeks 14 weeks 15 weeks 16 weeks 16 weeks 20 weeks

67 yr old Female (Definite scjd) 1 st saw a doctor Hospital admission Referred neurologist Seen by neurologist Notified to NCJDSU Seen by NCJDSU Died 8 weeks 14 weeks 14 weeks 15 weeks 16 weeks 16 weeks 20 weeks Very non-specific early symptoms No cognitive problems until 12 weeks

67 yr old Female (Definite scjd) CJD first suspected 1 st saw a doctor Hospital admission Referred neurologist Seen by neurologist Notified to NCJDSU Seen by NCJDSU Died 8 weeks 14 weeks 14 weeks 15 weeks 16 weeks 16 weeks 20 weeks

CONCLUSIONS

CLINICAL DIAGNOSIS IS DIFFICULT NON-SPECIFIC PRESENTATION OTHER DISEASES NEED TO BE EXCLUDED NO SIMPLE DIAGNOSTIC TEST PASSAGE OF TIME MAY BE IMPORTANT

SPORADIC CJD in the UK MEDIAN TIME IN MONTHS 2004 2006 2008 ONSET-DEATH 4.5 4.5 4.0 ONSET-DIAGNOSIS 3.95 3.97 3.69

COULD THIS TIME BE SHORTER? SYMPTOMS DIAGNOSIS

COULD THIS TIME BE SHORTER? SYMPTOMS DIAGNOSIS PROBABLY NOT AS THINGS STAND SIMPLE DIAGNOSTIC TEST WOULD HELP

COULD THIS TIME BE SHORTER? SYMPTOMS DIAGNOSIS PROBABLY NOT AS THINGS STAND SIMPLE DIAGNOSTIC TEST WOULD HELP

DIAGNOSIS TAKES TIME UNCERTAINTY

DIAGNOSIS TAKES TIME UNCERTAINTY AFFECTS PATIENT FAMILY & FRIENDS CLINICAL STAFF

DIAGNOSIS TAKES TIME UNCERTAINTY AFFECTS PATIENT FAMILY & FRIENDS CLINICAL STAFF

STAFF OF THE NCJDSU REFERRING DOCTORS PATIENTS & THEIR FAMILIES

STAFF OF THE NCJDSU REFERRING DOCTORS PATIENTS & THEIR FAMILIES

STAFF OF THE NCJDSU REFERRING DOCTORS PATIENTS & THEIR FAMILIES